1. Home
  2. GRNQ vs ERNA Comparison

GRNQ vs ERNA Comparison

Compare GRNQ & ERNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GRNQ
  • ERNA
  • Stock Information
  • Founded
  • GRNQ 2013
  • ERNA 2018
  • Country
  • GRNQ Malaysia
  • ERNA United States
  • Employees
  • GRNQ N/A
  • ERNA N/A
  • Industry
  • GRNQ EDP Services
  • ERNA Biotechnology: Pharmaceutical Preparations
  • Sector
  • GRNQ Technology
  • ERNA Health Care
  • Exchange
  • GRNQ Nasdaq
  • ERNA Nasdaq
  • Market Cap
  • GRNQ 10.6M
  • ERNA 10.2M
  • IPO Year
  • GRNQ 2018
  • ERNA N/A
  • Fundamental
  • Price
  • GRNQ $1.47
  • ERNA $1.20
  • Analyst Decision
  • GRNQ
  • ERNA
  • Analyst Count
  • GRNQ 0
  • ERNA 0
  • Target Price
  • GRNQ N/A
  • ERNA N/A
  • AVG Volume (30 Days)
  • GRNQ 21.5K
  • ERNA 80.1K
  • Earning Date
  • GRNQ 11-12-2025
  • ERNA 11-11-2025
  • Dividend Yield
  • GRNQ N/A
  • ERNA N/A
  • EPS Growth
  • GRNQ N/A
  • ERNA N/A
  • EPS
  • GRNQ N/A
  • ERNA N/A
  • Revenue
  • GRNQ $3,256,679.00
  • ERNA $488,000.00
  • Revenue This Year
  • GRNQ N/A
  • ERNA N/A
  • Revenue Next Year
  • GRNQ N/A
  • ERNA N/A
  • P/E Ratio
  • GRNQ N/A
  • ERNA N/A
  • Revenue Growth
  • GRNQ N/A
  • ERNA 201.24
  • 52 Week Low
  • GRNQ $0.80
  • ERNA $1.19
  • 52 Week High
  • GRNQ $2.50
  • ERNA $23.70
  • Technical
  • Relative Strength Index (RSI)
  • GRNQ 51.60
  • ERNA 34.66
  • Support Level
  • GRNQ $1.21
  • ERNA $1.19
  • Resistance Level
  • GRNQ $1.50
  • ERNA $1.57
  • Average True Range (ATR)
  • GRNQ 0.11
  • ERNA 0.14
  • MACD
  • GRNQ 0.02
  • ERNA 0.01
  • Stochastic Oscillator
  • GRNQ 76.32
  • ERNA 12.82

About GRNQ Greenpro Capital Corp.

Greenpro Capital Corp operates and provides business solution services to small and medium-sized businesses located in Southeast Asia and East Asia, with a focus on Hong Kong, China and Malaysia, and in Thailand and Taiwan. Its range of services includes cross-border business solutions, record management services, and accounting outsourcing services. Cross-border business services include other services, tax planning, trust and wealth management. Its segments include Service business engaged in the provision of corporate advisory and business solution services; Real estate business segment engaged in trading or leasing of commercial real estate properties in Hong Kong and Malaysia; and Digital business segment engaged in provision of digital platform and trading of digital assets.

About ERNA Eterna Therapeutics Inc.

Ernexa Therapeutics Inc is a biotechnology company. The company develops transformational new medicines using various cell engineering technologies for cancer and autoimmune diseases. The proprietary technology of the company transforms induced pluripotent stem cells (iPSCs) into induced mesenchymal stem cells (iMSCs), offering potential off-the-shelf treatment solutions without the need for patient-specific cell harvesting.

Share on Social Networks: